₹248.85
■ +0 +0.00%
29 Jul 2026
NSE Listed · Healthcare
Suraksha Diagnostic Ltd. (SURAKSHA)
Volume: 7,264Avg Vol 1W: 1,07,066Avg Vol 1M: 51,11652W Range:₹224.1₹333
Key Ratios
Checked 5h agoMarket Cap₹1,297 Cr
Current Price₹248.85
Previous Close₹248.85
High / Low (52w)₹333 / ₹224.1
Volume7,264
Avg Vol (1W)1,07,066
Avg Vol (1M)51,116
Stock P/E40.31
Book Value₹47.01
Dividend Yield20%
ROE13.15%
ROA7.01%
Revenue (TTM)—
Revenue Growth15.26%
Profit Margin10.37%
Total Debt₹3 Cr
Shares Outstanding5 Cr
Face Value₹2
EPS (TTM)₹6.18
P/B5.3
Debt / Equity0.46
50 DMA₹272.68
200 DMA₹279.47
Day change+0.00%
Price Chart
₹248.85▼ 18.82% · 1Y
2025-07-292026-07-29
20-day avg volume: 55K shares
Pros
- Pays a dividend yield of 20.0%.
- Company is almost debt-free.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹61 Cr | ₹67 Cr | ₹60 Cr | ₹65 Cr | ₹73 Cr | ₹79 Cr | ₹78 Cr | ₹81 Cr |
| EBITDA | ₹13 Cr | ₹16 Cr | ₹10 Cr | ₹11 Cr | ₹15 Cr | ₹15 Cr | ₹13 Cr | ₹14 Cr |
| Net Profit | ₹8 Cr | ₹10 Cr | ₹6 Cr | ₹7 Cr | ₹9 Cr | ₹9 Cr | ₹8 Cr | ₹6 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹66 Cr | ₹59 Cr | ₹64 Cr | ₹256 Cr | ₹70 Cr | ₹76 Cr | ₹76 Cr | ₹79 Cr |
| EBITDA | ₹16 Cr | ₹10 Cr | ₹12 Cr | ₹50 Cr | ₹16 Cr | ₹15 Cr | ₹14 Cr | ₹14 Cr |
| Net Profit | ₹11 Cr | ₹6 Cr | ₹8 Cr | ₹32 Cr | ₹10 Cr | ₹9 Cr | ₹8 Cr | ₹7 Cr |
| EPS | — | — | — | 5.97 | — | — | — | — |
Balance Sheet
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Total Assets | ₹173 Cr | ₹171 Cr | ₹201 Cr | ₹281 Cr | ₹300 Cr | ₹334 Cr |
| Total Liabilities | ₹53 Cr | ₹45 Cr | ₹51 Cr | ₹126 Cr | ₹121 Cr | ₹123 Cr |
| Equity | ₹120 Cr | ₹126 Cr | ₹150 Cr | ₹155 Cr | ₹179 Cr | ₹210 Cr |
| Total Debt | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Operating | ₹26 Cr | ₹49 Cr | ₹51 Cr | ₹69 Cr | ₹74 Cr |
| Investing | ₹-28 Cr | ₹-44 Cr | ₹-21 Cr | ₹-35 Cr | ₹-40 Cr |
| Financing | ₹3 Cr | ₹1 Cr | ₹-24 Cr | ₹-25 Cr | ₹-24 Cr |
| Free Cash Flow | ₹26 Cr | ₹49 Cr | ₹51 Cr | ₹69 Cr | ₹74 Cr |
Shareholding
Promoter 49.1% Institutions 36.7% Public 14.21%
Efficiency & Working Capital
ROCE14.4%
Interest Coverage5.6
Dividend Payout—
Debtor Days20 d
Inventory Days12 d
Payable Days20 d
Cash Conversion Cycle12 d
Working Capital Days32 d
Shareholding Details
As of 2026-06-30
Promoter49.1%
FII13.5%
DII23.2%
Institutions36.7%
Public14.2%
Promoter Pledge0.1%
No. of Shareholders64,866
Shareholding Pattern
Quarterly — figures in %. Latest 11 quarters.
| Period | Jul 2024 | Jul 2024 | Nov 2024 | Nov 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 72.4% | 72.4% | 61.1% | 61.1% | 48.8% | 48.8% | 48.9% | 49% | 49% | 49.1% | 49.1% |
| FIIs | 0% | 0% | 0% | 0% | 15.4% | 14.5% | 13.9% | 13.7% | 13.5% | 13.5% | 13.5% |
| DIIs | 27.6% | 0% | 0% | 0% | 20.4% | 22.1% | 22.4% | 22% | 22.6% | 23.1% | 23.2% |
| Public | 0% | 27.6% | -38.9% | 38.9% | 15.4% | 14.7% | 14.8% | 15.3% | 15% | 14.3% | 14.2% |
| Promoter Pledge | 65.9% | 65.9% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.1% | 0.1% |
| No. of Shareholders | 10 | 10 | 10 | 10 | 98,662 | 87,275 | 79,670 | 75,304 | 70,963 | 67,107 | 64,866 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Ritu Mittal | Shareholding of Promoter and Promoter Group | 15.9% | 82,95,437 |
| Orbimed Asia Ii Mauritius Limited | Public Shareholding | 12.9% | 67,06,711 |
| Satish Kumar Verma | Shareholding of Promoter and Promoter Group | 10.8% | 56,43,971 |
| Sarla Kejriwal | Shareholding of Promoter and Promoter Group | 9.2% | 48,09,062 |
| Nippon Life India Trustee Ltd-a/c Nippon India Pha | Public Shareholding | 7.5% | 38,96,349 |
| Kotak Small Cap Fund | Public Shareholding | 6.5% | 33,87,925 |
| Somnath Chatterjee | Shareholding of Promoter and Promoter Group | 5.1% | 26,54,768 |
| Tinni Investments Limited | Shareholding of Promoter and Promoter Group | 4.6% | 24,07,000 |
| Aditya Birla Sun Life Trustee Private Limited A/c | Public Shareholding | 3.8% | 19,74,513 |
| Dneema Overseas Private Limited | Shareholding of Promoter and Promoter Group | 3.2% | 16,69,562 |
| Carnelian Bharat Amritkaal Fund | Public Shareholding | 2.4% | 12,32,306 |
| Bandhan Balanced Advantage Fund | Public Shareholding | 1.3% | 6,88,395 |
| Aparajita Chatterjee | Shareholding of Promoter and Promoter Group | 0.1% | 52,533 |
| Bipul Mittal | Shareholding of Promoter and Promoter Group | 0% | 21,060 |
| Bipul Mittal Huf | Shareholding of Promoter and Promoter Group | 0% | 16,720 |
| Gayatri Bhattacharya | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Raj Bedi | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Goutam Chattopodhyay | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Tandra Chatterjee | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Bholanath Chattopadhyay | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Manjusri Chatterjee | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Tathagata Chatterjee | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Raman Kejriwal | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Poonam Kanodia | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Rinku Chirimar | Shareholding of Promoter and Promoter Group | 0% | 0 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Aparajita Chatterjee | 24,809 | 47.2% | 2026-06-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Somnath Chatterjee | Chairman & Joint M.D | 2025 |
| Ritu Mittal | Joint Managing Director & CEO | 2025 |
| Satish Verma | Non-Exec & Non-Independent Dir | 2025 |
| Arun Sadhanandham | Non-Exec & Non-Independent Dir | 2025 |
| PRADIP KUMAR DUTTA | Independent Non Exe. Director | 2025 |
| Ishani Ray | Independent Non Exe. Director | 2025 |
| Siddhartha Roy | Independent Non Exe. Director | 2025 |
| Dharam Chand Dharewa | Independent Non Exe. Director | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Diagnostic centers for carrying out | ₹0 Cr | — |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹2 | 12 | 10 | 10 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-08-25 | Dividend (0.5/- per share) | Final |
| dividend | 2026-08-25 | ₹0.5 (25%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 11 | 0 | 0 | 5 | 22 | 38 |
| 2025 | 9 | 0 | 0 | 0 | 1 | 10 |
| 2025 | 0 | 0 | 0 | 5 | 17 | 23 |
Insider / Designated-Person Trades
12 recent disclosure(s)
Aparajita ChatterjeeAcquisition · 9,000
Aparajita ChatterjeeAcquisition · 15,809
Aparajita ChatterjeeAcquisition · 6,234
Aparajita ChatterjeeAcquisition · 11,044
Aparajita ChatterjeeAcquisition · 10,446
BIPUL MITTAL HUFAcquisition · 1,445
Substantial Acquisitions (SAST)
4 disclosure(s)
Market18/08/2025 · 7,800
Market14/08/2025 · 8,200
Market13/08/2025 · 8,235
Market12/08/2025 · 8,190
Company Information
🌐 www.surakshanet.com ↗
📍 Plot No DG-12/1 Action Area 1D, Premieses No 02-0327 Rajarhat, Kolkata, West Bengal, 700156
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Supreme Industries Ltd.Supreme Infrastructure India Ltd.Supreme Power Equipment LimitedSupriya Lifescience Ltd.Suraj Estate Developers LimitedSuraj LimitedSurana Solar LimitedSurana Telecom and Power Ltd.Surani Steel Tubes Ltd.Suryalata Spinning Mill LimitedSuryalakshmi Cotton Mills Ltd.Surya Roshni Ltd.All “S” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search